High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints
MA Lisio, L Fu, A Goyeneche, Z Gao… - International journal of …, 2019 - mdpi.com
Among a litany of malignancies affecting the female reproductive tract, that of the ovary is the
most frequently fatal. Moreover, while the steady pace of scientific discovery has fuelled …
most frequently fatal. Moreover, while the steady pace of scientific discovery has fuelled …
Global cancer in women: burden and trends
This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …
[HTML][HTML] Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence
Collaborative Group on Hormonal Factors in Breast … - The Lancet, 2019 - Elsevier
Background Published findings on breast cancer risk associated with different types of
menopausal hormone therapy (MHT) are inconsistent, with limited information on long-term …
menopausal hormone therapy (MHT) are inconsistent, with limited information on long-term …
Ovarian cancer statistics, 2018
LA Torre, B Trabert, CE DeSantis… - CA: a cancer journal …, 2018 - Wiley Online Library
In 2018, there will be approximately 22,240 new cases of ovarian cancer diagnosed and
14,070 ovarian cancer deaths in the United States. Herein, the American Cancer Society …
14,070 ovarian cancer deaths in the United States. Herein, the American Cancer Society …
[HTML][HTML] Epidemiology of ovarian cancer: a review
BM Reid, JB Permuth, TA Sellers - Cancer biology & medicine, 2017 - ncbi.nlm.nih.gov
Ovarian cancer (OC) is the seventh most commonly diagnosed cancer among women in the
world and the tenth most common in China. Epithelial OC is the most predominant …
world and the tenth most common in China. Epithelial OC is the most predominant …
[HTML][HTML] Menopausal hormone therapy and women's health: An umbrella review
GQ Zhang, JL Chen, Y Luo, MB Mathur… - PLoS …, 2021 - journals.plos.org
Background There remains uncertainty about the impact of menopausal hormone therapy
(MHT) on women's health. A systematic, comprehensive assessment of the effects on …
(MHT) on women's health. A systematic, comprehensive assessment of the effects on …
Epidemiology of epithelial ovarian cancer
Highlights•Ovarian cancer is a major cause of mortality and case numbers are
increasing.•Five-year relative survival is below 45%.•Reproductive exposures strongly …
increasing.•Five-year relative survival is below 45%.•Reproductive exposures strongly …
Ovarian cancer
UA Matulonis, AK Sood, L Fallowfield… - Nature reviews Disease …, 2016 - nature.com
Ovarian cancer is not a single disease and can be subdivided into at least five different
histological subtypes that have different identifiable risk factors, cells of origin, molecular …
histological subtypes that have different identifiable risk factors, cells of origin, molecular …
2016 IMS Recommendations on women's midlife health and menopause hormone therapy
RJ Baber, N Panay, A Fenton - Climacteric, 2016 - Taylor & Francis
Abstract The International Menopause Society (IMS) has produced these new 2016
recommendations on women's midlife health and menopause hormone therapy (MHT) to …
recommendations on women's midlife health and menopause hormone therapy (MHT) to …
Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020
CJ Cabasag, PJ Fagan, J Ferlay… - … Journal of Cancer, 2022 - Wiley Online Library
Ovarian cancer remains to have relatively poor prognosis particularly in low‐resourced
settings. It is therefore important to continually examine the burden of ovarian cancer to …
settings. It is therefore important to continually examine the burden of ovarian cancer to …